New liquid chromatography-tandem mass spectrometry method for routine TDM of vancomycin in patients with both normal and impaired renal functions and comparison with results of polarization fluoroimmunoassay in light of varying creatinine concentrations

Abu-Shandi, 2009, Determination of vancomycin in human plasma using high - performance liquid chromatography with fluorescence detection, Anal. Bioanal. Chem., 395, 527, 10.1007/s00216-009-2948-9 Rybak, 2009, Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacist, Am. J. Health-Syst Pharm., 66, 82, 10.2146/ajhp080434 Backes, 1998, Quantitation of vancomycin and its crystalline degradation product (CDP-1) in human serum by high performance liquid chromatography, J. Pharm. Biomed. Ann., 16, 1281, 10.1016/S0731-7085(97)00140-4 Harris, 1983, Vancomycin: structure and transformation to CDP-1, J. Am. Chem. Soc., 105, 6915, 10.1021/ja00361a029 Sym, 2001, Fluorescence polarization immunoassay: can it result in an overestimation of vancomycin in patients not suffering from renal failure?, Ther. Drug Monit., 23, 441, 10.1097/00007691-200108000-00020 Melichercik, 2014, The effect of vancomycin degradation products in the topical treatment of osteomyelitis, Bratisl. Lek. Listy, 115, 796 Hadwiger, 2012, Quality assessment of US marketplace vancomycin for injection products using high resolution LC-MS and potency assays, Antimicrob. Agents Chemother., 10.1128/AAC.00164-12 Diana, 2003, Development and validation of an improved method for the analysis of vancomycin by liquid chromatography selectivity of reverse-phase columns towards vancomycin components, J. Chromatogr. A, 996, 115, 10.1016/S0021-9673(03)00535-1 Diana, 2006, Investigation of vancomycin and related substances by liquid chromatography/ion trap mass spectrometry, Rapid Commun. Mass Spectrom., 20, 685, 10.1002/rcm.2364 Wilson, 2003, Evaluation of commercial assays for vancomycin and aminoglycosides in serum: a comparison of accuracy and precision based on external quality assessment, J. Antimicrob. Chemother., 52, 78, 10.1093/jac/dkg296 Najjar, 1995, Comparison of high-performance liquid chromatography with fluorescence polarization immunoassay for the analysis of vancomycin in patients with chronic renal failure, J. Chromatogr. B, 672, 295, 10.1016/0378-4347(95)00220-D Lukša, 1995, Rapid high-performance liquid chromatographic determination of vancomycin in human plasma, J. Chromatogr. B, 667, 277, 10.1016/0378-4347(95)00033-F Li, 1995, An improved micromethod for vancomycin determination by high-performance liquid chromatography, Ther. Drug Monit., 17, 366, 10.1097/00007691-199508000-00009 Farin, 1998, A modified HPLC method for the determination of vancomycin in plasma and tissues and comparison to FPIA (TDX), J. Pharm. Biomed. Anal., 18, 367, 10.1016/S0731-7085(98)00095-8 Liu, 2007, Simultaneous determination of the purity and potency of vancomycin and norvancomycin by HPLC, Chromatografia, 65, 203, 10.1365/s10337-006-0134-1 de Jesus Valle, 2008, Development and validation of an HPLC method for vancomycin and its application to a pharmacokinetic study, J. Pharm. Biomed. Anal., 48, 835, 10.1016/j.jpba.2008.05.040 Ghassempour, 2001, Comparison of pyrolysis-mass spectrometry with high performance liquid chromatography for the analysis of vancomycin in serum, Talanta, 55, 573, 10.1016/S0039-9140(01)00460-X Shibata, 2003, Highly sensitive quantification of vancomycin in plasma samples using liquid chromatography-tandem mass spectrometry and oral bioavailability in rats, J. Chromatogr. B, 789, 211, 10.1016/S1570-0232(03)00068-0 Ahsman, 2009, Microanalysis of β-lactam antibiotics and vancomycin in plasma for pharmacokinetic studies in neonates, Antimicrob. Agents Chemother., 53, 75, 10.1128/AAC.00636-08 Cheng, 2010, LC-MS/MS method development and validation for the determination of polymyxins and vancomycin in rat plasma, J. Chromatogr. B, 878, 2831, 10.1016/j.jchromb.2010.08.037 Bijleveld, 2014, A simple quantitative method analysing amikacin, gentamicin and vancomycin levels in human newborn plasma using ion-pair liquid chromatography/tandem mass spectrometry and its applicability to a clinical study, J. Chromatogr. B, 951–9952, 110, 10.1016/j.jchromb.2014.01.035 Oyaert, 2015, Novel LC-MS/MS method for plasma vancomycin: comparison with immunoassays and clinical impact, Clin. Chim. Acta, 441, 63, 10.1016/j.cca.2014.12.012 König, 2013, Quantification of vancomycin in human serum by LC-MS/MS, Clin. Chem Lab. Med., 51, 1769, 10.1515/cclm-2013-0142 US Food and Drug Administration, 2001 2005, 41 Bland, 1986, Statistical methods for assessing agreement between two methods of clinical measurement, Lancet, 1, 307, 10.1016/S0140-6736(86)90837-8 Passing, 1983, A new biometrical procedure for testing equality of measurements from two different analytical methods, J. Clin. Chem. Clin. Biochem., 21, 709 Muppidi, 2013, Development and validation of rapid high-performance liquid chromatography method with UV detection for the determination of vancomycin in mouse plasma, J. Chromat. Separation Techniq., 4, 165 Van Eeckhaut, 2009, Validation of bioanalytical LC-MS/MS assays: evaluation of matrix effect, J. Chromatogr. B, 877, 2198, 10.1016/j.jchromb.2009.01.003 Chin, 2004, A study of matrix effects on an LC/MS/MS assay for olanzapine and desmethyl olanzapine, J. Pharm. Biomed. Anal., 35, 1149, 10.1016/j.jpba.2004.01.005 Brozmanová, 2010, Liquid chromatography-tandem mass spectrometry for simultaneous determination of cyclosporine A and its metabolites AM1, AM9 and AM4N in whole blood and isolated lymphocytes in renal transplant patients, J. Sep. Sci., 33, 2287, 10.1002/jssc.201000185 Uřinovská, 2012, Liquid-chromatography-tandem mass spectrometry method for determination of five antidepressants and four antipsychotics and their main metabolites in human serum, J. Chromatogr. B, 907, 101, 10.1016/j.jchromb.2012.09.009 Sistik, 2016, Fast simultaneous LC/MS/MS determination of 10 active compounds in human serum for therapeutic drug monitoring in psychiatric medication, Biomed. Chromatogr., 30, 217, 10.1002/bmc.3538 Azzazy, 1998, Abbott AxSYM vancomycin II assay: multicenter evaluation and interference study, Ther. Drug Monit., 20, 202, 10.1097/00007691-199804000-00011 Smith, 1998, New modified fluorescence polarization immunoassay does not falsely elevate vancomycin concentration in patients with end-stage renal disease, Ther. Drug Monit., 20, 231, 10.1097/00007691-199804000-00016